Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan, Melphalan, and Thiotepa with Allo-HSCT for High-Risk Ewing's Sarcoma
NCT00357396Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, melphalan, thiotepa in Ewing sarcoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2005; status: completed.
02
Drugs
busulfanmelphalanthiotepa
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT00357396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357396.